A study on pattern of medicines prescribed, adherence of medications to treatment guidelines and awareness of lifestyle modification in patients of polycystic ovary syndrome.
Not Applicable
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2019/07/020180
- Lead Sponsor
- Diamond Jubilee Society Trust KEM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients who are diagnosed cases of PCOS as per Rotterdamâ??s criteria (attached as appendix IV) by the treating physician and taking treatment for PCOS for minimum 3 months.
2. Females aged 15-45 years willing to participate in the study.
Exclusion Criteria
1. Cushingâ??s syndrome, non-classic congenital adrenal hyperplasia, hypogonadotropic hypogonadism, thyroid abnormalities, androgen-secreting tumours and hyperprolactinemia
2. Symptomatic disease (liver, kidney, heart, CNS or other symptomatic diseases) and Malignancy disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the pattern of drug use in treatment of polycystic ovary syndrome patients. <br/ ><br>2. To assess the adherence of physician in prescribing the medication following the Indian guidelines for the management of PCOS by Indian Fertility Society Good Clinical Practice: PCOS Guidelines and International Evidence based guidelines. <br/ ><br>Timepoint: Single point (cross sectional study), 18 months duration.
- Secondary Outcome Measures
Name Time Method 1. To evaluate patterns of clinical manifestations in PCOS patients <br/ ><br>2. To assess the awareness of lifestyle modification in patients of PCOS <br/ ><br>Timepoint: Single point (cross sectional study), 18 months duration.